Anugerah 88 Logo
$1.160.00|(0.00%)
52W H: 2.61652W L: 1.09Beta: 0.99

About Coherus Oncology Inc

Frequently Asked Questions

What is the 52-week range for CHRS?

The 52-week high is $2.616 and the 52-week low is $1.09.

What is the P/E ratio for CHRS?

The P/E ratio data is currently unavailable.

What is the dividend yield for CHRS?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -183.36%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -259.41%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 2.81.

Analyst Recommendation Trends

Wall Street analyst consensus for CHRS over the last few months:

2026-09-01
Buy: 6
S.Buy: 4
Hold: 2
Sell: 0
2026-08-01
Buy: 6
S.Buy: 5
Hold: 2
Sell: 0
2026-07-01
Buy: 6
S.Buy: 5
Hold: 2
Sell: 0
2026-06-01
Buy: 6
S.Buy: 5
Hold: 2
Sell: 0

Latest CHRS News

Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets

- Oppenheimer Initiates a Robust Process with Global Reach for the Benefit of Shareholders -REDWOOD CITY, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS) today announced that it has initiated the process to market and sell the remaining assets associated with the Company’s former biosimilars business (the “Legacy BioSim Assets”). The Company has retained Oppenheimer & Co. Inc. (“Oppenheimer”) to serve as its financial advisor in connection with the sale. Parties

Yahoo9/23/2026

Coherus Oncology, Inc. (CHRS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Coherus Oncology, Inc. (CHRS) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 12:20 PM EDTCompany ParticipantsDennis Lanfear -...

SeekingAlpha9/16/2026

Related Stocks (Peers)

Companies operating in similar sectors to CHRS:

ELDNALECCUENKTXCNTNCHRSPYXSDTILORGOAVXLALXO950160.KQ

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-06-05Satvat Ali J.+60,000--
2026-06-05Satvat Ali J.+30,000--
2026-06-05Karachun Rita A+60,000--
2026-06-05Karachun Rita A+30,000--
2026-06-05Newcomer Lee Nisley+60,000--
2026-06-05Newcomer Lee Nisley+30,000--
2026-06-05Ryan Michael Lee+60,000--
2026-06-05Ryan Michael Lee+30,000--
2026-06-05O'Donnell-Tormey Jill+60,000--
2026-06-05O'Donnell-Tormey Jill+30,000--
2026-06-05Newton Charles W.+60,000--
2026-06-05Newton Charles W.+30,000--
2026-06-05Wahlstrom Mats+60,000--
2026-06-05Wahlstrom Mats+30,000--
2026-05-29McMichael Bryan J+30,000--
2026-05-29McMichael Bryan J+25,000--
2026-05-29McMichael Bryan J+25,000--
2026-05-29McMichael Bryan J+15,000--
2026-05-29McMichael Bryan J+25,000--
2026-05-29McMichael Bryan J+100,000--
2026-05-29McMichael Bryan J-30,000--
2026-05-29McMichael Bryan J-25,000--
2026-05-29McMichael Bryan J-25,000--
2026-05-29McMichael Bryan J-15,000--
2026-05-29McMichael Bryan J-25,000--
2026-05-29McMichael Bryan J-100,000--
2026-05-29Lanfear Dennis M+225,000--
2026-05-29Lanfear Dennis M+402,500--
2026-05-29Lanfear Dennis M+402,500--
2026-05-29Lanfear Dennis M+125,000--
2026-05-29Lanfear Dennis M+500,000--
2026-05-29Lanfear Dennis M+500,000--
2026-05-29Lanfear Dennis M+450,000--
2026-05-29Lanfear Dennis M+400,000--
2026-05-29Lanfear Dennis M+200,000--
2026-05-29Lanfear Dennis M-225,000--
2026-05-29Lanfear Dennis M-402,500--
2026-05-29Lanfear Dennis M-402,500--
2026-05-29Lanfear Dennis M-125,000--
2026-05-29Lanfear Dennis M-500,000--
2026-05-29Lanfear Dennis M-500,000--
2026-05-29Lanfear Dennis M-450,000--
2026-05-29Lanfear Dennis M-400,000--
2026-05-29Lanfear Dennis M-200,000--
2026-01-23Lanfear Dennis M+750,000--
2026-01-23Lanfear Dennis M+375,000--
2026-01-22McMichael Bryan J+225,000--
2026-01-22McMichael Bryan J+112,500--
2026-01-20McMichael Bryan J-1,715$1.55$2,658
2026-01-20Lanfear Dennis M-11,839$1.55$18,350